Anti-apoptotic protein Bcl-xL encoded by BCL2L1 was identified as a prognostic marker in cholangiocarcinoma depending on anatomical subtypes when it indicated beneficial prognosis, especially for pCCA (131). Here, BCL2L1 is linked to cholangiocarcinoma.